Giulio Mondellini

35 posts

Giulio Mondellini banner
Giulio Mondellini

Giulio Mondellini

@GiulioMonde

🇮🇹 | Cardiology - @ErasmusMC 🇳🇱 | Adjunct Research Scientist - @Columbia CUIMC/NYP 🇺🇸

Katılım Mart 2020
242 Takip Edilen114 Takipçiler
Giulio Mondellini retweetledi
Dr. Gilbert Tang
Dr. Gilbert Tang@GilbertTangMD·
REGULAR ISSUE Multimodality Assessment of a Culprit LAD Myocardial Bridge in a Patient With Congenital Heart Disease jacc.org/doi/10.1016/j.… Infected Coronary Artery Aneurysm Within Chronically Occluded Stents jacc.org/doi/10.1016/j.… Simultaneous Myocardial and Mesenteric Ischemia Mimicking Each Other in an Older Patient jacc.org/doi/10.1016/j.… Hybrid Transcatheter and Endoscopic Retrieval of a Pulmonary Artery–Embolized ASD Occluder in Hemodynamic Compromise jacc.org/doi/10.1016/j.… RotaRadial: First Use of Rotational Atherectomy as a Bailout Strategy for Severely Calcified Radial Access jacc.org/doi/10.1016/j.… Inadvertent Left Ventricular Implantation of a Leadless Pacemaker Managed by Percutaneous Extraction jacc.org/doi/10.1016/j.… Surgical Tricuspid Valve Repair Resulting in Acquired Gerbode Defect: A Rare and Challenging Case jacc.org/doi/10.1016/j.… Clinic Strategy of Gerbode Defects jacc.org/doi/10.1016/j.… The de Winter–Wellens Continuum: Evidence of Dynamic Bidirectional Coronary Collateral Flow in Acute Coronary Syndrome jacc.org/doi/10.1016/j.… Inferior Vena Cava Filter Strut Embolized Across the Interventricular Septum to the Left Ventricular Apex jacc.org/doi/10.1016/j.… IVC Tric Valve Regurgitation Treatment With Ballooning Expanding the Valve After Downsizing With a Nonpremounted Stent jacc.org/doi/10.1016/j.… Pulmonary Hypertension Hyper-Responder to Valve-in-Valve TMVR Under Conscious Sedation jacc.org/doi/10.1016/j.… Ring Dehiscence From Right Fibrous Trigone Misidentification jacc.org/doi/10.1016/j.… Transcatheter Paravalvular Leak Closure Using Valve Frame Access jacc.org/doi/10.1016/j.… Late-Onset Perinodal Atrial Tachycardia After Transcatheter Atrial Septal Device Closure jacc.org/doi/10.1016/j.… Transvenous Lead Extraction for Tricuspid Regurgitation and Right Atrial Enlargement Induced by an Atrial Lead jacc.org/doi/10.1016/j.… Preventing Inadvertent Cannulation Into the Vein of Marshall With a Useful Fluoroscopic Landmark jacc.org/doi/10.1016/j.… VF Arrest at Rest in a Teenager With Anomalous Origin of Coronaries and DSG2 Variant jacc.org/doi/10.1016/j.… Fundamental Anatomy and Its Impact on Clinical Practice: Bachmann’s Bundle and Interatrial Conduction Block (Part I-III) jacc.org/doi/10.1016/j.… Interatrial Conduction Pacing: All Roads May Lead to Rome, but Which One Should We Take? jacc.org/doi/10.1016/j.… Intermittent High-Grade Atrioventricular Block as a Presenting Sign of Left Ventricular Noncompaction jacc.org/doi/10.1016/j.… Physiological Pacing and Cardiomyopathies: A Future Ahead jacc.org/doi/10.1016/j.… Advanced Heart Failure in Friedreich's Ataxia: A Story of Challenges, Opportunities, and Hope jacc.org/doi/10.1016/j.… Giant Isolated Congenital Left Atrial Appendage Aneurysm Complicated by Thrombus: Multimodality Imaging Assessment jacc.org/doi/10.1016/j.… Migration of Fragments of Inferior Vena Cava Filter to Heart and Lung jacc.org/doi/10.1016/j.… Multimodality Imaging of a Pulmonary Valve Papillary Fibroelastoma Associated With Pulmonary Embolism jacc.org/doi/10.1016/j.… Progressive Subvalvular Right Ventricular Outflow Tract Obstruction With a Single Coronary Artery in an Adult jacc.org/doi/10.1016/j.… Rosai-Dorfman Disease in a Rare Cardiac Presentation: Left Ventricular Mass Causing Ventricular Tachycardia jacc.org/doi/10.1016/j.… Value of Multimodality Imaging in the Early Diagnosis of Intravascular and Intracardiac Leiomyomatosis jacc.org/doi/10.1016/j.… Purulent Pneumopericardium From a Gastropericardial Fistula 30 Years After Gastrectomy jacc.org/doi/10.1016/j.… The Trojan Horse Around the Heart: Pneumopericardium Revealing Gastropericardial Fistula jacc.org/doi/10.1016/j.… Colchicine-Responsive Dacron Hypersensitivity After Bentall Procedure: A Rare Trigger of Diffuse Coronary Artery Disease jacc.org/doi/10.1016/j.… Physician-Modified Micropore Stent Graft Resolves Thoracic Aneurysms Combined With Behçet's Disease jacc.org/doi/10.1016/j.… Extreme Malignant Hypertension Resulting in Dialysis-Dependent Hypertensive Nephrosclerosis jacc.org/doi/10.1016/j.… Hemorrhagic Myocardial Infarction Implicating Left Ventricular Thrombus jacc.org/doi/10.1016/j.… Author’s handles: @M_Pompeu_Sa_MD @HarryDauerman @DrTGupta @MGalloMD @eyadalhaj @sofivilasanjuan @drnvanmieghem @GiulioMonde @SomPSingh @GTsigkas @kalazizimd @khawar_achakzi @mhd_osa @al_hajhouj @a_h_ghoneem @fangjonathanx @OmarSamiZaki @SachinGoelMD @KharsaChloe @KrityaMangesh @slittlemd @KharsaChloe @davidgzcasal @DamianSanc1955 @JustinTretterMD @davidgzcasal @kirsten_ar @KeyurVoraMD
English
0
5
8
914
Giulio Mondellini retweetledi
American Heart Association
American Heart Association@American_Heart·
The American Heart Association mourns the passing of the legendary cardiologist Eugene Braunwald, M.D., widely recognized as one of the most influential figures in the history of cardiovascular medicine. Over seven decades, his work reshaped the understanding and treatment of heart disease, leading many to call him the father of modern cardiology. Braunwald was a lifelong contributor to the American Heart Association, helping advance its research and scientific mission, and was honored with some of the Association’s highest honors for his lasting influence on cardiovascular care and research. His influence extended well beyond his own discoveries, as generations of Association‑supported investigators, clinicians and academic leaders were trained by Braunwald or guided by the clinical trial standards and mentorship models he helped establish. newsroom.heart.org/news/american-…
English
68
898
2.2K
441K
Giulio Mondellini retweetledi
Circulation
Circulation@CircAHA·
#SimPub #ACC26 HEPARIN STEMI RCT: Pre-hospital UFH at first medical contact improved pre-PCI TIMI 2-3 flow without excess bleeding. Supports routine prehospital anticoagulation in STEMI referred for primary PCI. @DaniloFrancoMD ahajrnls.org/4theyfI
Circulation tweet media
English
1
25
51
9.2K
Giulio Mondellini retweetledi
C. Michael Gibson MD
C. Michael Gibson MD@CMichaelGibson·
Dr. Misa Fister and Dr. C. Michael Gibson discuss the UFH-STEMI trial: Pretreatment with IV unfractionated heparin at first medical contact improved infarct-related artery patency without excess bleeding among patients with STEMI. #ACC26 Watch video here: clinicaltrialresults.org/dr-misa-fister…
English
0
8
22
3.4K
Giulio Mondellini
Giulio Mondellini@GiulioMonde·
Amazing days at #ACC26 in NOLA 🎷 presenting our work on PV loops after Tricuspid TEER! Hemodynamics are key to decoding the biventricular impact of TEER🫀 📈 Deep dive into physiology + catching up with colleagues in the Big Easy! ⚜️ @JACCJournals @ACCinTouch
Giulio Mondellini tweet mediaGiulio Mondellini tweet mediaGiulio Mondellini tweet media
New Orleans, LA 🇺🇸 English
0
0
3
102
Giulio Mondellini retweetledi
Andrew P. Ambrosy, MD, MPH
Andrew P. Ambrosy, MD, MPH@AndrewPAmbrosy·
AMI-CS remains a high-mortality condition despite advancements in treatment. The DanGer Shock trial is the first positive RCT for MCS in AMI-CS. Key factors: optimal patient phenotype, timely MCS deployment, and rigorous care protocols (link.springer.com/article/10.100…). Read now in #HREV
English
0
2
4
358
Giulio Mondellini
Giulio Mondellini@GiulioMonde·
· 1st outpatient visit is a landmark event for #LVAD pts, marking the transition to chronic care: chance to make an impact · Clinical monitoring🩺, pump⚙️ & medication 💊optimization, are crucial to keep pts out-of-hospital
English
0
0
0
117
Giulio Mondellini
Giulio Mondellini@GiulioMonde·
Among 167 #HM3 patients: - 74.9% had at least 1 readmission over 900days, (median fu= 2 years) - 62% had unplanned readmissions within the 1st year, median time to first event: 115 days - Common causes: infections 🦠(29.3%) & bleeding (13.2%)🩸
English
1
0
0
171
Giulio Mondellini
Giulio Mondellini@GiulioMonde·
Captivating question at cardiogenic shock session #HeartFailure2024 are SBP/MAP target enough to adequately tailor pressors/inotropes? PP and DBP are also relevant, as suggested by @FH_Verbrugge Meaningful discussion and great panel of experts in the field! #HFA_ESC
Giulio Mondellini tweet media
English
0
4
14
1.1K
Giulio Mondellini
Giulio Mondellini@GiulioMonde·
Still many things to understand ahead Who benefits the most, from which strategy and when? Escalation for non responders?
English
1
0
3
159
Giulio Mondellini
Giulio Mondellini@GiulioMonde·
1st RCT to demonstrate MCS survival benefit in CS-AMI Milestone study: target population and prompt unloading may have played a role?
NEJM@NEJM

Presented today at #ACC24: In the DanGer Shock trial involving patients with STEMI and cardiogenic shock, mortality at 6 months was lower with mechanical circulatory support with a microaxial flow pump than with standard care alone. Full trial results: nej.md/3xyXU3t

English
1
1
6
545
Giulio Mondellini
Giulio Mondellini@GiulioMonde·
➡️Overlooking this common yet critical disorder can hinder proper treatment👀 ➡️Understanding its putative mechanisms is pivotal for effective management⭐️ ➡️In-depth knowledge of available therapeutic tools is key for achieving complete decongestion in this patient population🗝️
English
0
0
2
165